Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis.

Background: Conventional hemodialysis (CHD) is associated with suboptimal clinical outcomes and high mortality rates. Daily hemodialysis (DHD) has been reported to improve outcomes and quality of life (QOL), predominantly in self-care or home dialysis populations. The effect of short DHD (sDHD) on patients with end-stage renal disease (ESRD) with high comorbidities has not been established.

Nursing experience with daily dialysis at El Camino Hospital.

This article describes the daily dialysis experience of patients at El Camino Dialysis Services (ECDS) and discusses the nursing issues affected by daily dialysis. As the renal population grows, the treatment of end stage renal disease (ESRD) needs further examination to improve quality of life, reduce mortality rates, and lower costs. There are several reports of improved well-being in patients receiving increased frequency of dialysis.

Global ESRD Costs Associated with a Short Daily Hemodialysis Program in the United States.

In spite of the growing evidence that daily hemodialysis (DHD) improves clinical outcomes and quality of life, the additional dialysis costs are not currently reimbursed in the United States. Nor have there been reports of the effects of DHD on end-stage renal disease (ESRD) global costs, which would help predict the financial impact of DHD on the ESRD program. Since 1996, 22 patients (20 in-center, 2 home) have switched from conventional thrice-weekly dialysis to short, daily dialysis with six treatments per week.